"Prairie King's Professional Household" fell!
Presumably, many people today have received this news from the Internet: on December 12, the famous actor Tu Men died at the age of 61 due to illness at 3:50 today. In his acting career, Tu Men starred in a series of "Wang Ye" roles, heroic and atmospheric, not angry and arrogant, known as "Prairie Wangye Professional Household". One of the more well-known characters is "Genghis Khan", which premiered in 1985.
Today, countless fans mourn online, and what surprises everyone is not the death of an actor, but the only one month from the onset of illness to death. What is it that develops so quickly that it is finally powerless to return to heaven? It is the high incidence of esophageal cancer in China. Teacher Tu Men checked for advanced esophageal cancer in early last month, and underwent two chemotherapy treatments in Beijing, and finally the treatment was ineffective.
To what extent is the high incidence of esophageal cancer in China? Every year, half of the world's new patients and deaths of esophageal cancer are in China. Esophageal cancer has always been known as "poor cancer", especially in rural and remote mountainous areas. In the border areas of Hebei, Shanxi and Henan provinces, the incidence of esophageal cancer is much higher than in other places.
The early detection rate of esophageal cancer in China is very low, most of which are in the middle and advanced stages, and the overall 5-year survival rate is only 20-30%. Why the early detection rate is low, because Gastroscopy in China is not included in the basic physical examination project, and the early screening rate is very low. Patients with early stages of esophageal cancer may have no symptoms or only some mild atypical symptoms, which are often easily overlooked due to lack of specificity. It can be said that the vast majority of early esophageal cancers are difficult to detect without gastroscopy.
Patients with early esophageal cancer may have the following mild symptoms: occasional pinprick pain behind the sternum during the hypophanx, dryness and contraction in the throat, choking foreign body sensation when swallowing food, chest stuffiness, etc., these symptoms do not appear from time to time and are not easy to detect.
Therefore, for people at high risk of esophageal cancer, when they feel that they have the above symptoms, they must perform gastroscopy in time and carry out iodine staining of the esophageal mucosa, and when the lesion is uncertain, they can do accurate magnification endoscopy.
People at high risk for esophageal cancer include:
The following 10 categories of people over 40 years old: 1. from areas with a high incidence of esophageal tumors;
2. Have a family history of esophageal cancer;
3. People who eat too fast, eat high-temperature foods or pickled foods for a long time;
4. People who smoke for a long time or drink heavily;
5. People with poor oral hygiene;
6. People with esophageal arrhasia and corrosive stenosis;
7. Patients with Barrett esophageal risk factors or newly discovered endoscopic esophagus as Barrett's esophagus;
8. People infected with papillomavirus;
9. People with head and neck squamous cell carcinoma or respiratory squamous cell carcinoma have an increased risk of re-developing esophageal cancer;
10. People who have previous gastrectomy or atrophic gastritis.
What should I do if I find esophageal cancer?
1. Surgical treatment is preferred for those who can operate, and adjuvant chemotherapy or radiotherapy is selected according to the pathological stage after surgery. Radical radiotherapy or concurrent chemoradiotherapy is preferred for those who cannot tolerate surgery due to poor cardiopulmonary function or reluctance to operate.
2. For locally advanced esophageal cancer that cannot be operated on, consider neoadjuvant chemotherapy or neoadjuvant concurrent chemoradiotherapy, and then evaluate whether surgery can be performed. If R0 resection is possible, postoperative immunotherapy is maintained.
3. Inoperable local advanced esophageal cancer is recommended to have simultaneous chemoradiation, followed by chemotherapy combined with immunotherapy, and immunotherapy is maintained for one year.
4. The current guidelines for advanced esophageal cancer recommend first-line chemotherapy combined with immunotherapy, and the best supportive therapy is preferred for those with poor constitution.